Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
755 trials across Europe, recruiting first
Efficacy and Safety of Once‑Daily Oral ASC30 in Adults with Obesity or Overweight: A Phase III Randomized Placebo‑Controlled Trial
CzechiaA Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes
CzechiaEffect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
BulgariaA Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
BulgariaA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
CzechiaA Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus
BulgariaZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
BulgariaA study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis
BulgariaA study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis
BulgariaA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
AustriaA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
AustriaA Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
BulgariaThe therapies tested most often in Metabolism and nutrition disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
